Coming Up With New Logo

Get 20% Free Customization In This Report

Glycated Hemoglobin Testing Market by Product (Laboratory HbA1c Testing Products and Point of Care (POC) HbA1c Testing Products), by Technology (Chromatography and Immunoassay), and by End User (Hospitals, Physical Examination Institution, and Research Institutions) - Global Opportunities and Industry Forecasts, 2017-2023

  • ID: LI 174142
  • Mar 2018
  • NA pages
  • Price: $4028

Glycated hemoglobin is used to measure three-month average plasma glucose concentration. It is a standardized test that indicates the amount of HbA1c, a special form of glycated hemoglobin, in a persons blood during the past two to four months. A glycated hemoglobin test is used to diagnose type 2 diabetes by monitoring the amount of hemoglobin bound to the glucose.

The major factors that contribute to the growth of the glycated hemoglobin testing market include increasing diabetic patients, growing geriatric population, technological advancements in diagnosing diabetes, growth in the home healthcare market, and increased R&D activities in early diagnosis and efficient disease management. However, the availability of substitutes and high costs associated with glycated hemoglobin testing hinder the market growth. Increase in diabetic population and growing awareness about POC HbA1c testing in developing countries are expected to boost the market growth in the near future.

The glycated hemoglobin testing market is segmented on the basis of product, technology, end user, and region. On the basis of product type, the market is segmented into Laboratory HbA1c testing products and point of care (POC) HbA1c testing products. Based on technology, the market is segmented into chromatography, immunoassay, and others. On the basis of end user, the market is classified into hospitals, physical examination institution, research institutions, and others. By geography, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Alere Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Bayer AG, Randox Laboratories Ltd., Tosoh Corporation, ARKRAY, Inc., and A.Menarini Diagnostics Ltd.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
  • Key market players within the market have been profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the global market.

Glycated Hemoglobin Testing Market Key Segments:

By Product Type

  • Laboratory HbA1c Testing Products
  • Point of Care (POC) HbA1c Testing Products

By Technology

  • Chromatography
  • Immunoassay
  • Others

By End User

  • Hospitals
  • Physical Examination Institution
  • Research Institutions
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models


2.1 CXO Perspective


3.1 Market Definition and Scope
3.2 Porter’s Five Forces Analysis
3.3 Market Share Analysis, 2016
3.4 Market Dynamics

3.4.1 Drivers
3.4.2 Restraints
3.4.3 Opportunities


4.1 Overview
4.2 Market size and forecast
4.3 Laboratory HbA1c Testing Products

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Point of Care (POC) HbA1c Testing Products

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast


5.1 Overview
5.2 Market size and forecast
5.3 Chromatography

5.3.1 Market size and forecast
5.4 Immunoassay
5.4.1 Market size and forecast

5.5 Others

5.5.1 Market size and forecast


6.1 Overview
6.2 Market size and forecast
6.3 Hospitals

6.3.1 Market size and forecast

6.4 Physical Examination Institution

6.4.1 Market size and forecast

6.5 Research Institutions

6.5.1 Market size and forecast

6.6 Others

6.6.1 Market size and forecast


7.1 Overview

7.1.1 Market size and forecast 

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast U.S. market size and forecast Canada market size and forecast Mexico market size and forecast

7.2.4 North America glycated hemoglobin testing market by product type
7.2.5 North America glycated hemoglobin testing market by technology
7.2.6 North America glycated hemoglobin testing market by end user

7.3 Europe 

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast Germany market size and forecast France market size and forecast UK market size and forecast Italy market size and forecast Spain market size and forecast Rest of Europe market size and forecast

7.3.4 Europe glycated hemoglobin testing market by product type
7.3.5 Europe glycated hemoglobin testing market by technology
7.3.6 Europe glycated hemoglobin testing market by end user

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast Japan market size and forecast China market size and forecast India market size and forecast South Korea market size and forecast Rest of Asia-Pacific market size and forecast

7.4.4 Asia-Pacific glycated hemoglobin testing market by product type
7.4.5 Asia-Pacific glycated hemoglobin testing market by technology
7.4.6 Asia-Pacific glycated hemoglobin testing market by end user


7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast Brazil market size and forecast Saudi Arabia market size and forecast South Africa market size and forecast Rest of LAMEA market size and forecast

7.5.4 LAMEA glycated hemoglobin testing market by product type
7.5.5 LAMEA glycated hemoglobin testing market by technology
7.5.6 LAMEA glycated hemoglobin testing market by end user


8.1 Abbott Laboratories

8.1.1 Overview 
8.1.2 Company snapshot 
8.1.3 Business performance 
8.1.4 Operating segment overview
8.1.5 Strategic moves and developments 

8.2 F. Hoffmann-La Roche Ltd.

8.2.1 Overview 
8.2.2 Company snapshot 
8.2.3 Business performance 
8.2.4 Operating segment overview
8.2.5 Strategic moves and developments 

8.3 Alere Inc.

8.3.1 Overview 
8.3.2 Company snapshot 
8.3.3 Business performance 
8.3.4 Operating segment overview
8.3.5 Strategic moves and developments 

8.4 Bio-Rad Laboratories, Inc.

8.4.1 Overview 
8.4.2 Company snapshot 
8.4.3 Business performance 
8.4.4 Operating segment overview
8.4.5 Strategic moves and developments

8.5 Beckman Coulter, Inc.

8.5.1 Overview 
8.5.2 Company snapshot 
8.5.3 Business performance 
8.5.4 Operating segment overview
8.5.5 Strategic moves and developments 

8.6 Bayer AG

8.6.1 Overview 
8.6.2 Company snapshot 
8.6.3 Business performance 
8.6.4 Operating segment overview
8.6.5 Strategic moves and developments 

8.7 Randox Laboratories Ltd.

8.7.1 Overview 
8.7.2 Company snapshot 
8.7.3 Business performance 
8.7.4 Operating segment overview
8.7.5 Strategic moves and developments 

8.8 Tosoh Corporation 

8.8.1 Overview 
8.8.2 Company snapshot 
8.8.3 Business performance 
8.8.4 Operating segment overview
8.8.5 Strategic moves and developments

8.9 ARKRAY, Inc. 

8.9.1 Overview 
8.9.2 Company snapshot 
8.9.3 Business performance 
8.9.4 Operating segment overview
8.9.5 Strategic moves and developments

8.10 A.Menarini Diagnostics Ltd. 

8.10.1 Overview 
8.10.2 Company snapshot 
8.10.3 Business performance 
8.10.4 Operating segment overview
8.10.5 Strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.


Get More Information About This Report

For any queries about purchasing this report, For any queries, please fill the form below:

Please input the above text in the input box or click refresh









* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at

Send Enquiry

Why Allied Market Research


Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Readings


Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts